CN103191339B - 一种治疗小儿贲门失弛缓症药物的制备方法 - Google Patents
一种治疗小儿贲门失弛缓症药物的制备方法 Download PDFInfo
- Publication number
- CN103191339B CN103191339B CN201310107720.3A CN201310107720A CN103191339B CN 103191339 B CN103191339 B CN 103191339B CN 201310107720 A CN201310107720 A CN 201310107720A CN 103191339 B CN103191339 B CN 103191339B
- Authority
- CN
- China
- Prior art keywords
- parts
- brown
- parched
- fructus
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 201000000621 achalasia Diseases 0.000 title claims abstract description 20
- 208000000289 Esophageal Achalasia Diseases 0.000 title claims abstract description 19
- 206010030136 Oesophageal achalasia Diseases 0.000 title claims abstract description 19
- 229940079593 drug Drugs 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 239000000341 volatile oil Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000001556 precipitation Methods 0.000 claims abstract description 4
- 238000005507 spraying Methods 0.000 claims abstract description 4
- 230000000747 cardiac effect Effects 0.000 claims description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 14
- 240000005498 Setaria italica Species 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 4
- 241000282461 Canis lupus Species 0.000 abstract description 3
- 241001672694 Citrus reticulata Species 0.000 abstract description 3
- 241000244987 Daiswa polyphylla Species 0.000 abstract description 3
- 240000005979 Hordeum vulgare Species 0.000 abstract description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract description 3
- 244000302544 Luffa aegyptiaca Species 0.000 abstract description 3
- 235000009814 Luffa aegyptiaca Nutrition 0.000 abstract description 3
- 244000197580 Poria cocos Species 0.000 abstract description 3
- 235000008599 Poria cocos Nutrition 0.000 abstract description 3
- 241000983344 Trachelospermum jasminoides Species 0.000 abstract description 3
- 235000007226 Setaria italica Nutrition 0.000 abstract 3
- 244000293889 Bombax malabaricum Species 0.000 abstract 2
- 235000004480 Bombax malabaricum Nutrition 0.000 abstract 2
- 241000158764 Murraya Species 0.000 abstract 2
- 244000184734 Pyrus japonica Species 0.000 abstract 2
- 238000007873 sieving Methods 0.000 abstract 1
- 238000003809 water extraction Methods 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 210000003238 esophagus Anatomy 0.000 description 8
- 108091006146 Channels Proteins 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 210000002318 cardia Anatomy 0.000 description 4
- 230000004899 motility Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000005070 sphincter Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 240000001899 Murraya exotica Species 0.000 description 2
- 235000008766 Murraya exotica Nutrition 0.000 description 2
- 235000009696 Murraya paniculata Nutrition 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229960001597 nifedipine Drugs 0.000 description 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000017521 Artemisia japonica Nutrition 0.000 description 1
- 241000271889 Artemisia japonica Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 244000188192 Murraya paniculata Species 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 241000220151 Saxifragaceae Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 229940125713 antianxiety drug Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000003618 cortical neuron Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229960004166 diltiazem Drugs 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 229960000201 isosorbide dinitrate Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 239000000050 smooth muscle relaxant Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310107720.3A CN103191339B (zh) | 2013-03-31 | 2013-03-31 | 一种治疗小儿贲门失弛缓症药物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310107720.3A CN103191339B (zh) | 2013-03-31 | 2013-03-31 | 一种治疗小儿贲门失弛缓症药物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103191339A CN103191339A (zh) | 2013-07-10 |
CN103191339B true CN103191339B (zh) | 2015-03-11 |
Family
ID=48714272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310107720.3A Expired - Fee Related CN103191339B (zh) | 2013-03-31 | 2013-03-31 | 一种治疗小儿贲门失弛缓症药物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103191339B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103463335A (zh) * | 2013-08-19 | 2013-12-25 | 郝永波 | 一种治疗突发性耳聋外用散剂的制备方法 |
-
2013
- 2013-03-31 CN CN201310107720.3A patent/CN103191339B/zh not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
食管-贲门失弛缓症证治探讨;齐贺彬 等;《北京中医》;20070630;第26卷(第06期);345-346 * |
Also Published As
Publication number | Publication date |
---|---|
CN103191339A (zh) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103495040B (zh) | 治疗反流性食管炎的中药组合物及其颗粒剂制备方法 | |
CN103432475B (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN102772778A (zh) | 一种治疗暑湿感冒的中药组合物 | |
CN102166278B (zh) | 一种治疗小儿类风湿性关节炎的中药组合物及其制备方法 | |
CN103191339B (zh) | 一种治疗小儿贲门失弛缓症药物的制备方法 | |
CN103142897B (zh) | 一种贲门失弛缓症术后用药 | |
CN103495103B (zh) | 消食健脾的药物 | |
CN103142898B (zh) | 一种贲门失弛缓症术后用药的制备方法 | |
CN103191338B (zh) | 一种治疗小儿贲门失弛缓症的药物组合物 | |
CN103191336B (zh) | 一种治疗食道失弛缓症药物的制备方法 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN103191335B (zh) | 一种治疗食道失弛缓症的药物组合物 | |
CN106344838A (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN106177736A (zh) | 一种缓解肠胃不适引起便秘的艾叶保健茶及其制备方法 | |
CN105902766A (zh) | 治疗消化性溃疡的药物及制备方法 | |
CN104922595A (zh) | 一种用于带状疱疹的中药制剂及其制备方法 | |
CN104173707A (zh) | 一种治疗梅核气的中药膏 | |
CN104474440A (zh) | 用于治疗仔猪营养不良性贫血的药物组合物及其制备方法 | |
CN103142899A (zh) | 一种治疗脊柱骨骺发育不良药物的制备方法 | |
CN104784260A (zh) | 一种提高肿瘤患者术后免疫功能的中药片剂及制备方法 | |
CN103301378B (zh) | 一种治疗儿童夜尿症的药物组合物 | |
CN115364185A (zh) | 一种通降胃气治疗胃胀的中药片剂 | |
CN108969670A (zh) | 一种用于治疗痰瘀交阻型中风的中药组合物 | |
CN103191337A (zh) | 一种食道失弛缓症术后用药的制备方法 | |
CN105998835A (zh) | 一种用于治疗产后抑郁症的药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHONGXIN HOSPITAL, QINGDAO Free format text: FORMER OWNER: MOU LIPING Effective date: 20150129 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Xigong Inventor after: Wang Zhan Inventor after: Gong Qi Inventor after: Mou Liping Inventor before: Mou Liping |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276826 RIZHAO, SHANDONG PROVINCE TO: 266042 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: MOU LIPING TO: WANG XIGONG WANG ZHAN GONG QI MOU LIPING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150129 Address after: 127 Qingdao Central Hospital, four South Stream Road, Shandong, Qingdao 266042, China Applicant after: Zhongxin Hospital, Qingdao Address before: 276826 Rizhao People's Hospital, 126 Tai'an Road, Shandong, Rizhao City, China Applicant before: Mou Liping |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150311 Termination date: 20160331 |